Penumbra Inc. has announced its next phase for vascular franchise growth with U.S. commercial availability of the Indigo System Lightning 12 and the appointments of Corey L. Teigen, MD, to chief scientific officer; and James F. Benenati, MD, FSIR, to chief medical officer – two newly created positions. Innovating the

  Penumbra has acquired 40 percent of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90 percent, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters. The joint venture intends to commercialize healthcare applications of virtual reality technology,